[F2] Flash Talk (Even no.)

4:57 PM - 4:58 PM JST(7:57 AM - 7:58 AM UTC)R&D IIIImmunology

[F2-16] Development of a Highly Sensitive Neutralizing Antibody Assay in Mucosal Samples from Mice, Non-human Primates, and Humans for Nasal COVID-19 Vaccine Research

*Meito Shibuya^1,2,3, Seiki Shirai^1,2,3, Morio Nagira^1,2,3, Takahito Ito³, Mina Yamamoto^2,3, Hiroshi Kiyono^1,2,4,5,6,7, Kotaro Fujihashi^1,2,7,8,9 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba (Japan), 3. Vaccine R&D Laboratory, Vaccine Business Division, Shionogi & Co., Ltd. (Japan), 4. Future Medicine Education and Research Organization, Chiba University, Chiba (Japan), 5. Department of Medicine, UC San Diego School of Medicine, San Diego, CA (USA), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine, San Diego, CA (USA), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba (Japan), 8. Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo (Japan), 9. Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham AL (USA))

Password required to view

Log in

or